Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 233,391
  • Shares Outstanding, K 41,090
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,010 K
  • 60-Month Beta 1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.12
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.19 +35.56%
on 09/19/19
6.84 -16.96%
on 09/26/19
+1.42 (+33.33%)
since 09/18/19
3-Month
3.47 +63.69%
on 07/22/19
6.84 -16.96%
on 09/26/19
+2.14 (+60.45%)
since 07/18/19
52-Week
1.67 +240.12%
on 12/20/18
6.84 -16.96%
on 09/26/19
+2.97 (+109.59%)
since 10/18/18

Most Recent Stories

More News
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that Dr. Heather Wilson-Robles DVM, DACVIM, Associate Professor and Dr. Fred and Vola N. Palmer Chair in Comparative Oncology, Texas...

VNRX : 5.68 (+4.60%)
Volition Appoints Dr. Phillip Barnes to Board of Directors

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the appointment of Dr. Phillip Barnes to the Company's Board of Directors as a Non-Executive Director, effective October 9, 2019. Dr....

VNRX : 5.68 (+4.60%)
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced a significant milestone in its Nu.QTM Capture development program: the ability to enrich nucleosomes, and therefore, DNA of tumor versus...

VNRX : 5.68 (+4.60%)
VolitionRX Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 13, 2019 / VolitionRX Ltd. (NYSE: ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 13, 2019 at 8:30 AM Eastern Time....

VNRX : 5.68 (+4.60%)
VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June 30, 2019. Volition management will host a conference call...

VNRX : 5.68 (+4.60%)
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the recent formation of a subsidiary, Volition Veterinary Diagnostics Development LLC ("Volition Veterinary"), and the appointment...

VNRX : 5.68 (+4.60%)
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call on Tuesday, August 13 at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter...

VNRX : 5.68 (+4.60%)
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced a further strengthening of its balance sheet with an existing investor exercising the balance of its warrant to purchase $4.8 million...

VNRX : 5.68 (+4.60%)
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun...

VNRX : 5.68 (+4.60%)
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately $1.4 million...

VNRX : 5.68 (+4.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade VNRX with:

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

2nd Resistance Point 6.01
1st Resistance Point 5.85
Last Price 5.68
1st Support Level 5.47
2nd Support Level 5.25

See More

52-Week High 6.84
Last Price 5.68
Fibonacci 61.8% 4.87
Fibonacci 50% 4.26
Fibonacci 38.2% 3.64
52-Week Low 1.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar